These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8773463)

  • 21. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O; Hudecová S; Orlický J; Zachar J
    Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diltiazem derivatives modulate the dihydropyridine-binding to intact rat ventricular myocytes.
    Kanda S; Kurokawa J; Adachi-Akahane S; Nagao T
    Eur J Pharmacol; 1997 Jan; 319(1):101-7. PubMed ID: 9030904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
    Nakajima M; Adachi I; Ueda M
    Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of L-type Ca2+ channels in portal vein myocytes by the enantiomers of oxodipine.
    Baron A; Rakotoarisoa L; Leprêtre N; Mironneau J
    Eur J Pharmacol; 1994 Sep; 269(1):105-13. PubMed ID: 7828652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Density and localization of calcium channels of the L-type in human pulmonary artery.
    Amenta F; Bisetti A; Bronzetti E; Coppola L; Felici L; Ferrante F; Mariotta S; Ricci A
    Clin Exp Hypertens; 1998 May; 20(4):389-402. PubMed ID: 9607402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
    Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
    Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
    Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue.
    Rutledge A; Triggle DJ
    Eur J Pharmacol; 1995 Jul; 280(2):155-8. PubMed ID: 7589180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
    Kanda S; Adachi-Akahane S; Nagao T
    Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CP-060S interacts with three principal binding sites on the L-type Ca2+ channel.
    Suzuki Y; Tamura K; Adachi Y; Fukazawa M; Kato T
    Eur J Pharmacol; 1998 Jan; 342(2-3):347-51. PubMed ID: 9548407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
    Ferry DR; Kaumann AJ
    Br J Pharmacol; 1987 Mar; 90(3):447-57. PubMed ID: 2436700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
    Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.